Top Stories
-
Patients who participate in fewer than two visits early in treatment are at risk for relapse, overdose, and possible death.
Topic
-
Source:
The New York TimesJermaine Jones, PhD, a neuroscientist at Columbia, teaches people to rouse individuals experiencing a fentanyl overdose by giving them a firm rub with their knuckles in the center of the chest.
-
Source:
Associated PressKatherine Keyes, director of Columbia’s Psychiatric Epidemiology Training Program, testified at an ongoing trial against three major pharmaceutical companies regarding the opioid epidemic.
-
Source:
Big BrainsAn opioid addiction vaccine is currently in the first phase of clinical trials, being led by Columbia Psychiatry's Sandra Comer, who directs the university’s Opioid Laboratory.
Latest News
-
Source:
NBC NewsJuly 16, 2021“Our study provides further evidence that marijuana use is not effective in reducing nonmedical opioid use,” said study author Dr. Mark Olfson.
-
Source:
MedscapeDecember 15, 2020"[Buprenorphine] is a tremendously powerful medication, saves many lives and prevents overdose, but there is a risk of misuse and diversion, albeit pretty low," says Dr. Francis Levin.
- November 16, 2020
The Substance Abuse and Mental Health Services Administration has awarded $32 million to the American Academy of Addiction Psychiatry to address opioid use disorders and stimulant use disorders.
Topic
- June 3, 2020
“More than any other provider group, primary care providers offer greater potential for expanding access to buprenorphine treatment,” says Dr. Mark Olfson.
Topic
- March 6, 2020
Dr. Edward V. Nunes will serve as one of the directors of Columbia's Center for Healing of Opioid and Other Substance Use Disorders-Enhancing Intervention, Development and Implementation (CHOSEN).
-
Source:
ABC NewsJanuary 28, 2020"Our results highlight the critical need to improve buprenorphine treatment services, especially for the youngest with opioid use disorder," Dr. Mark Olfson said.
Topic
-
Source:
UPIJanuary 23, 2020"Our results highlight the critical need to improve buprenorphine treatment services, especially for the youngest with opioid use disorder," Dr. Mark Olfson said.
Topic
- January 21, 2020
National statistics on medication treatment for opioid addiction show that buprenorphrine use is increasing in all age groups except the young.
Topic
-
Source:
MedscapeJanuary 9, 2020"We were surprised to learn that there has been a larger decrease in opioid prescribing to adults with more rather than less severe pain," Dr. Mark Olfson said.
Topic
-
Source:
U.S. NewsDecember 17, 2019"Considering the high risk of suicide after nonfatal opioid overdose, this information could be especially valuable in suicide prevention efforts," Dr. Mark Olfson said.
Topic
